Fig. 1. Concentration-response curves to levcromakalim (10−8to 10−5m) in the absence and in the presence of glibenclamide (10−5m), obtained in the rat thoracic aorta with or without endothelium. Data are shown as means ± SD and expressed as percent of maximal relaxation induced by papaverine (3 × 10−4m; 100%= 1,060 ± 134 mg [n = 5] and 1,020 ± 305 mg [n = 5] for control rings with endothelium or rings treated with glibenclamide, 100%= 1,045 ± 91 mg [n = 4] and 1,030 ± 289 mg [n = 4] for control rings without endothelium or rings treated with glibenclamide, respectively). * Difference between control rings and rings treated with glibenclamide is statistically significant (P < 0.05).

Fig. 1. Concentration-response curves to levcromakalim (10−8to 10−5m) in the absence and in the presence of glibenclamide (10−5m), obtained in the rat thoracic aorta with or without endothelium. Data are shown as means ± SD and expressed as percent of maximal relaxation induced by papaverine (3 × 10−4m; 100%= 1,060 ± 134 mg [n = 5] and 1,020 ± 305 mg [n = 5] for control rings with endothelium or rings treated with glibenclamide, 100%= 1,045 ± 91 mg [n = 4] and 1,030 ± 289 mg [n = 4] for control rings without endothelium or rings treated with glibenclamide, respectively). * Difference between control rings and rings treated with glibenclamide is statistically significant (P < 0.05).

Close Modal

or Create an Account

Close Modal
Close Modal